Volume | 280,548 |
|
|||||
News | - | ||||||
Day High | 0.0986 | Low High |
|||||
Day Low | 0.0273 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Oncology Institute Inc | TOIIW | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0504 | 0.0273 | 0.0986 | 0.0443 | 0.0998 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
564 | 280,548 | $ 0.0376259 | $ 10,556 | - | 0.022 - 0.3699 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 600 | $ 0.0443 | USD |
Oncology Institute Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
809.76M | 73.75M | - | 324.24M | -83.07M | -1.13 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Oncology Institute News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TOIIW Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.099 | 0.0998 | 0.0273 | 0.0998 | 108 | -0.0547 | -55.25% |
1 Month | 0.2475 | 0.2475 | 0.025 | 0.1084389 | 10,419 | -0.2032 | -82.10% |
3 Months | 0.2958 | 0.2975 | 0.025 | 0.1559903 | 9,219 | -0.2515 | -85.02% |
6 Months | 0.18 | 0.3699 | 0.025 | 0.1865016 | 7,806 | -0.1357 | -75.39% |
1 Year | 0.0327 | 0.3699 | 0.022 | 0.097796 | 11,895 | 0.0116 | 35.47% |
3 Years | 1.775 | 1.775 | 0.022 | 0.5466909 | 17,184 | -1.73 | -97.50% |
5 Years | 1.775 | 1.775 | 0.022 | 0.5466909 | 17,184 | -1.73 | -97.50% |
Oncology Institute Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. |